CANTATA: A randomized phase 2 study of CB-839 in combination with cabozantinib vs. placebo with cabozantinib in patients with advanced/metastatic renal cell carcinoma Meeting Abstract
| Authors: | Tannir, N. M.; Motzer, R. J.; Agarwal, N.; Liu, P. Y.; Whiting, S. H.; O'Keeffe, B.; Tran, X.; Fiji, G. P.; Escudier, B. |
| Abstract Title: | CANTATA: A randomized phase 2 study of CB-839 in combination with cabozantinib vs. placebo with cabozantinib in patients with advanced/metastatic renal cell carcinoma |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 266s |
| Language: | English |
| ACCESSION: | WOS:000442916007656 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.TPS4601 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS4601 -- Source: Wos |
